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Abstract: The association of smart mobile devices and lab-on-chip technologies offers unprecedented
opportunities for the emergence of direct-to-consumer in vitro medical diagnostics applications.
Despite their clear transformative potential, obstacles remain to the large-scale disruption and
long-lasting success of these systems in the consumer market. For instance, the increasing level of
complexity of instrumented lab-on-chip devices, coupled to the sporadic nature of point-of-care
testing, threatens the viability of a business model mainly relying on disposable/consumable
lab-on-chips. We argued recently that system evolvability, defined as the design characteristic
that facilitates more manageable transitions between system generations via the modification of an
inherited design, can help remedy these limitations. In this paper, we discuss how platform-based
design can constitute a formal entry point to the design and implementation of evolvable smart
device/lab-on-chip systems. We present both a hardware/software design framework and the
implementation details of a platform prototype enabling at this stage the interfacing of several
lab-on-chip variants relying on current- or impedance-based biosensors. Our findings suggest that
several change-enabling mechanisms implemented in the higher abstraction software layers of the
system can promote evolvability, together with the design of change-absorbing hardware/software
interfaces. Our platform architecture is based on a mobile software application programming interface
coupled to a modular hardware accessory. It allows the specification of lab-on-chip operation and
post-analytic functions at the mobile software layer. We demonstrate its potential by operating a
simple lab-on-chip to carry out the detection of dopamine using various electroanalytical methods.
Keywords: lab-on-chip; smartphone; point-of-care; system evolvability; platform-based design;
electrochemistry
1. Introduction
Lab-on-Chip (LoC) technologies are pivotal in the emergence of Point-of-Care (PoC) In Vitro
Medical Diagnostics (IVMD) applications. They have been offering increasingly more diverse,
integrated and better performing IVMD analytical features. From the early and now common
lateral-flow immunoassays, several LoC families have evolved towards complex, instrumented
devices relying on actuated flows and advanced biosensing schemes [1]. LoCs have repeatedly
demonstrated significant functional capabilities ranging from cell sorting [2], rare cell isolation [3],
down to single-cell [4] or single-molecule analyses [5].
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Recently, advances in microfluidic Very Large-Scale Integration (mVLSI) [6], droplet [7] and
digital-microfluidics [8,9] have opened up new horizons for LoC design, operation and applicability.
For instance, by leveraging high component densities [10] and microfluidic logic [11–13], mVLSI
technology is promoting the emergence of software-programmable LoCs. Instrumented and
programmable LoCs have extended the scope of possible on-chip chemical and biological testing
at the expense of increased system integration challenges and often of stringent instrumentation and
control requirements. As argued by Erickson et al. [14], the costs and complexity of LoC/instrument
integration have constituted one of the roadblocks to the generalization of direct-to-consumer PoC,
LoC-based systems.
Smart mobile technologies may be transformative in addressing that challenge: the ubiquity,
functionality panel and computational power of smart devices make them particularly suitable for
coping with the aforementioned instrumentation and control issues. Numerous successful examples
of coupled smart device/LoC systems have been described in the literature. A recent review of
proof-of-concept systems and applications is available in [15]. Although some smart device/LoC
systems do not involve control functions and only make use of the smartphone camera for optical
readout purposes, we can anticipate that the increasing level of LoC automation is likely to affect
the functional role of smart devices in next generation smart device/LoC systems. A recent example
is provided by Li et al. [16], who proposed an Android-based platform allowing the control of
a Hardware Accessory (HWA) with embedded solenoid valves and pressure controllers. Several LoC
variants can be interfaced to the HWA and execute the appropriate flow actuation scheme required for
their correct operation. The sequence of valve actuations and pressure sensor readouts is defined via
a programming interface at the mobile Android-software layer.
This example, along with many other recent developments, has partly confirmed
the transformative potential of smart mobile technologies for promoting the emergence of
home/field-based PoC IVMD testing. Yet another major socio-technical roadblock still hinders
the success of direct-to-consumer IVMD systems: their low frequency of use [14]. Unlike glucose
monitoring, many IVMD tests only need to be performed sporadically depending on the time scale
and clinical significance of the variations exhibited by the biomarkers of interest. As consumer
market PoC IVMD systems mainly rely on an instrument/consumable business model, the combined
effects of limited system utility, expected low consumable sales volumes and high development
costs of systems of increasingly high complexity may jeopardize system adoption and success.
We highlighted this limitation in recent publications [17,18] and suggested that de novo system
design should be avoided, promoting instead system reuse and incremental system evolution, in
order to limit implementation and validation costs, reduce time-to-market, facilitate the integration
of new technologies and decrease the risk of early system obsolescence. We argue that system
evolvability, defined as “a design characteristic that facilitates more manageable transitions between
system generations via the modification of an inherited design and [...] by the ability of an architecture
to be inherited and changed across generations [over time]” [19], can assist in that attempt and thus help
remedy some of the socio-technical limitations still preventing the generalization of direct-to-consumer
IVMD systems. In this paper, we discuss how Platform-Based Design (PBD) constitutes a valid
formal entry-point for the design of evolvable systems. We first present the mechanisms by which
this may be pursued before illustrating our strategy with a case study: we elaborate on the design
and implementation of an evolvable smart device/LoC platform accommodating at this stage
high-impedance and electrochemical biosensing.
2. Evolvable Systems and Platform-Based Design
Platform-Based Design (PBD) frameworks and methodologies aim at decreasing product
development time and the costs of customization [20]. Cost savings are achieved by sharing a common
set of components, modules and/or subsystems across various product derivatives. The group of
related product variants constitutes the platform product family.
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The Google ARA platform, for instance [21], constitutes a particularly interesting example of PBD:
it aims at offering extended and user-personalized mobile phone functionality through plug-and-play
swappable modules (e.g., camera lens, GPS tracker, etc.). The Google ARA or similar concepts
could thus soon support product platforming of LoC-based PoC diagnostic testing, where variants
would materialize by modular Hardware Accessories (HWA), themselves interfacing disposable LoCs
presenting varying architectures, functions or operation. The differentiation of the LoC modules
is to this day still inevitable in order to address specific biological targets and to meet appropriate
biosensing performance requirements.
There is an intrinsic tension in PBD: the will to reuse as many core components as possible
between product variants and the wish for the widest panel of variants, which requires singular
product characteristics [22]. PBD therefore comprehends all of the challenges of system design,
while adding the complexity of platform-specific tradeoffs, such as maximizing commonality while
minimizing performance loss, minimizing costs, maximizing variety, etc. [20]. Sangiovanni-Vincentelli
famously conceptualized the foundation of PBD for Cyber-Physical Systems (CPS) [23,24]. The PBD
methodology for CPS is largely applicable to the design of smart device/LoC system hardware and
software. It involves the specification of the platform function space (Figure 1), which comprehends
the set of elementary functions that the system must provide in order to fulfil the anticipated use cases.
A given function (i.e., function instance) is meant to be allocated to a specific architecture variant. This
particular architecture instance should fall within the platform architectural space. This allocation
or mapping process is a key feature of CPS platforms. It is often carried out in search of meeting
pre-defined optimality criteria (e.g., mapping a function on the architecture that will perform the
fastest, etc.).
Fu
in
cture 
nce
Platform
mapping
Platform
design-space
export
Figure 1. CPS PBD in an uncertain environment. Changing context and requirements may necessitate
the expansion of both the function and architectural space. Design principles for favoring platform
evolvability are meant to facilitate that expansion at minimum costs and efforts. Adapted from [23].
Although PBD promotes the cost- and time-efficient development of a set of anticipated product
variants, it does not intrinsically favor system evolutions when these fall outside of the design
space initially considered. The development of LoC variants presenting architectural or functional
specificities incompatible with the initial platform hardware and software design specifications may
thus require substantial re-engineering costs and efforts. Worse, the standardization of the core
hardware and software elements of the platform may actually “limit the innovation and creativity
[at the LoC level] by locking the system into specific suppliers and technologies” [25]. Finally, the
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change of shared hardware/software components in a non-evolvable platform may propagate to
several product variants, threatening overall architecture stability or resulting in unbearable costs [26].
PBD can thus represent a powerful strategy to address new needs rapidly and to capitalize on
existing developments if these new needs can be satisfied by variants developed within the initial
platform function and architecture space. If not, the platform must also be capable of accommodating
the new variants in an agile and cost-effective manner: it must be evolvable.
The evolution of CPS platforms can be conceptualized by the expansion of the initial function
or architectural space (expansion arrows in Figure 1). Evolvability then translates how smoothly
these expansions can occur across platform generations. Among possible strategies to favor smart
device/LoC platform evolvability, one may follow Madni’s recommendations [25] to: (1) identify the
commonalities shared by the anticipated platform variants, i.e., in functions, structures and operations
throughout the the smart device, HWA and LoC sub-systems; (2) locate where in the platform hardware
and software architecture change-absorbers and change-enablers need to be implemented; and
(3) leverage design principles/systems architectural patterns to implement change-enabling/absorbing
mechanisms into the initial platform hardware and software in anticipation of alternative LoC variants.
3. Evolvable Platform Early Design Specification
3.1. Function Space Definition and Change-Enabling Mechanisms
The specification of the initial function space offered by a CPS platform is determinant in
promoting system-level evolvability. Fundamental change-enabling mechanisms should be considered
at this early stage. Design principles, such as those suggested by Fricke and Schultz [27] (Table 1),
are meant to guide the specification of enduring system architectures. They do not imply specific
technologies or implementations.
Table 1. Fricke and Schultz’s design principles for changeability [27].
Ideality/simplicity
Independence
Modularity/encapsulation
Integrability
Autonomy
Scalability
Non-hierarchical integration
Decentralization
Redundancy
Non-hierarchical integration: By presenting interfaces at the same hierarchical level, structures
or functions can be linked and interact in a more direct manner. LoC, HWA, mobile software and
cloud computing functions can, for instance, all be made available to the LoC application designer via
interfaces built at the mobile software layer, propagating the specification of LoC variants’ architectures
and functionality mapping at a higher level of abstraction.
Composability and modularity: Modular system architectures can facilitate the re-use, exchange
or adaptation of modules to perform new or more performant functionalities. As detailed in [18], our
HWA and software design relies on modular functions, which we distinguish as follows (Figure 2a):
Elementary Tasks (ETs) describe physical or computational functions performed at the HWA or
LoC level. ETs were defined so as to be composable: they can be composed/associated together while
keeping their intrinsic properties, to help realize LoC or HWA physical or computational functions
of higher complexity/utility than what each single ET can offer individually. We refer to these
compositions as Low-Level Tasks (LLTs) [18,28]. Finally High-Level Tasks (HLTs) are functions that are
computational-only and realized in the higher abstraction layers of the system: in mobile software
or in the cloud. One of the motivations behind these functional distinctions is the pivotal role of ETs
Diagnostics 2016, 6, 33 5 of 17
and LLTs in defining overall system operation. HLTs arguably form a vast function space, which may
extend from data analytics, to machine learning or cloud computing, whereas ETs and LLTs will be tied
to HWA and LoC physical processes, which we expect will considerably constrict the physical function
space offered by the platform. The modularity and composability of ETs, LLTs and HLTs should enable
the specification of LoC programs, i.e., sequences of tasks required for operating a given LoC variant
in an appropriate manner (Figure 2). The platform mapping process then consists of associating each
constituent function of an LoC program to the relevant structural component(s).
HW A
LOC
(a) (b)
Figure 2. (a) Generic illustrative example. The LoC program starts with a high-level task HLT1 carried
out by in the cloud followed by a low-level task LLT1 performed by the HWA. A predicate on the
execution of HLT2 conditions the next task to be executed: if the program branches to ET2, the program
eventually ends by HLT3; otherwise, it loops to the beginning. (b) Cyclic voltammetry acquisitions are
carried out successively at decreasing sensitivities if current saturation is detected within the potential
range where calibration is carried out. Cyclic voltammetry LLT1 is composed of two synchronous
elementary tasks: triangular waveform generation and synchronous sampling.
Independence: Each ET is independent; it alone can provide a useful function without relying on
other functions.
Ideality/simplicity: Since ETs will much likely represent the constricting element of the platform
function space (they are tied to the physical processes occurring on the LoC or the HWA), they must
be carefully defined during initial design. In order to offer the greatest potential for composing LLT
functions of enhanced utility, it may be tempting to specify ETs responsible for carrying out very
fundamental operations. Let us for instance consider ETs enabling the control of each and every single
register of an Analog to Digital Converter (ADC) embedded in the HWA. If they are composable, then
the composition of LLTs from these ETs will present the broadest panel of options for controlling the
signal acquisition process. Nevertheless, the complexity associated with this functional decomposition
may be burdening, since it requires handling low-level embedded software behavior at a higher level
of abstraction. The system is highly configurable, but at what cost? On the other hand, if the only
ET associated with ADC control triggers an entire sequence of acquisitions with hard-coded settings,
then few composition options remain, and it may be difficult to design LLTs offering enhanced utility.
The ideality/simplicity principle can guide utility/complexity tradeoffs, suggesting the definition
of “only useful/independent functions, which may be interpreted as establishing small, simple
units/elements with a minimized number of interfaces (loose coupling among and strong cohesion
within modules)”. By defining ideal/simple ETs, we should promote changeability.
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3.2. Change-Absorbing Interfaces
The design of modular systems requires that the coupling between system modules be minimized
while the integrity within modules is maximized. This coupling most often depends on the design
of the interfaces associating hardware or software modules between them. Modularity is a powerful
concept only if change to a module does not propagate to other modules and if the interfaces between
modules remain unaltered. Changing interfaces, especially, is often cumbersome and costly [26].
Lindermann et al. differentiate “local changes”, which are changes confined within a module, from
“interface-overlapping changes”, which often become inevitable as the system grows in complexity
and connectivity [29]. When properly designed, modular system architectures can facilitate the re-use,
exchange or adaptation of modules to perform new or more performant functionalities. The definition
of system interfaces is therefore critical in attempting to uncouple system modules and, thus, to
limit the propagation of change from one module to the others. Functional or structural module
interfaces often behave as change-carriers or multipliers, which means that changing these interfaces
may result in cascaded needs for re-engineering other system modules [30]. The two main interfaces
of an evolvable smart device/HWA/LoC platform, i.e., the wireless or electrical interface linking the
smart device to the HWA and the physical interface coupling the HWA to the LoC, should prevent
these cascading effects: they should be designed as change-absorbers.
3.3. Architecture Variants and Mapping
The definition of the platform’s initial hardware and software function space comes hand-in-hand
with the need to adequately abstract the platform architectural space. Both of these processes effectively
require to “cyberize the physical” [31] (Figure 3). Specifically, the elementary structural components
of a generic LoC, i.e., the LoC cells and the constituents of the interfacing HWA (Figure 3) should be
representable at the application layer. These abstracted representations (e.g., biosensors, actuators,
embedded processor) should display standardized interfaces to enable their associations, composition,
inter-communication, etc. (e.g., the HWA electrical I/O terminals). These, in turn, should make it
possible to represent the complete physical architecture of any of the HWA/LoC variants initially
considered, as well as alternative variants, unavailable at the initial design time.
Figure 3. (a) Abstraction of the LoC and HWA structural components at the mobile software layer.
The physical structures of the LoC and the interfaces enabling their associations are “cyberized” at the
mobile software layer [31] in order to enable the definition of LoC variants’ architectures. (b) Once both
the platform function space and platform architectural space are defined, mechanisms need to be
implemented in order to allow the functional allocation of ETs to the relevant structural components of
the HWA or LoC: the application mapping.
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The availability of these structural elements and association or composition rules are fundamental
to enable the platform design-space export of LoC/HWA variants. This process is key in PBD for
CPS: it conditions the automated mapping of platform functions to the target architecture according
to pre-defined optimality criteria [24,32]. Formal design-space export methods for optimal mapping
were not investigated further within the scope of this work and can be the object of future research.
4. Case Study: Evolvable Platform for Current- and Impedance-Based Biosensing
The primary objective of our case study is to illustrate the application of the introduced framework
for the design of an evolvable smart device/LoC platform initially enabling LoC application designers
to leverage current- or impedance-based biosensing on LoC variants presenting structural, functional
or operational specificities. These variants may for instance be differentiated from one another by
the number of sensors they embed or by the instrumentation settings for operating these sensors, etc.
The second requirement of an evolvable platform should be to facilitate the expansion of both functional
and architectural space in anticipation of needed change, such as for the accommodation of a new
biosensing technology.
We consider the blank-canvas design of an evolvable smartphone-based IVMD platform
relying on the Silicon Nanowire biological Field Effect Transistor (SiNW-bioFET) technology [33].
Largely inspired by the principle of operation of conventional MOS-FETs, SiNW-bioFETs have
repeatedly demonstrated their potential for the highly sensitive detection of various biomarkers
at ultra-low concentrations [34–40]. Specific surface chemistries, i.e., biofunctionalization schemes,
theoretically allow the adaptation of the sensor to a wide variety of targets and applications.
One of the derived requirements for leveraging the SiNW-bioFET technology is to couple it with
a sensitive instrumentation in order to be able to recover the concentration of the target analyte
from the sub-nanoampere currents flowing through the sensor. The lock-in synchronous detection
technique represents a potent instrumentation candidate as it offers both the possibility to recover
signals buried in high levels of noise and to reliably quantify signals that may vary in amplitude
or frequency over several orders of magnitude [38,39,41–47]. The technique requires, in our
particular case, a sensitive current pre-amplification. This latter requirement constitutes an interesting
commonality between SiNW-bioFETs and a variety of other current-based or impedimetric biosensors,
including electrochemical biosensors. Electrochemical methods for biological sensing of electro-active
compounds have been widely investigated in the field of mobile health in vitro diagnostics testing,
mainly on the account of their low cost and relative simplicity [48–51]. The identification of this
commonality served the definition of the initial platform function space.
4.1. Change-Enabling Functional and Structural Specification
Functional specification: Rather than specifying a stand-alone lock-in amplification function, we
decomposed its functionality guided by the modularity/composability and ideality design principles
previously introduced (Tables 1 and 2). From this functional decomposition, we designed the
object-oriented programming classes that would form the initial set of ETs offered by the platform.
These classes were made available through an iOS Application Programming Interface (API), enabling
the non-hierarchical integration of physical and computational tasks at the mobile software layer.
These ETs can be assembled to compose the electroanalytical acquisition functions useful for the
operation of electrochemical sensors. A UMLclass diagram representing the relations between
objectified ETs and the advanced electroanalytical LLTs is given in Figure 4.
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Table 2. Functional composition of a lock-in amplification acquisition. The acquisition settings, i.e.,
design variables of the function, can be mapped to the different parameters available through the
elementary tasks offered by the platform.
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Voltage Waveform Generation Current Acquisition DSP
Figure 4. Electrochemical analysis acquisition LLTs’ decomposition.
Voltage waveform generation, digital signal acquisition and digital signal processing functions
formed the independent, modular and composable functional blocks required for the specification
of amperometry, Cyclic-Voltammetry (CV), Square-Wave Cyclic Voltammetry (SWCV), Differential
Pulse Voltammetry (DPV), impedance measurements by lock-in amplification and Electrochemical
Impedance Spectroscopy (EIS). The design variables for each of these LLTs could be matched to the
settings offered by the three ETs (Table 2).
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Structural specification: As we mentioned earlier, the functionality of a cyber-physical platform is
achieved by granting the application designer the possibility to map the available platform functions
to a target architecture. As our application software layer is highly abstracted, we leverage object
orientation to derive software representations of the physical objects involved in system functionality.
The basic abstractions of the LoC, its embedded components and interfaces are presented in Figure 5.
Figure 5. iOS software classes for the main LoC architectural components and their relation to the
HWA/LoC interfacing terminals.
The POCLOC class is compartmentalized into LOCCells. These cells are referenced to in
an array structure. POCCell is an abstract class that refers to all of the embedded components
on the LoC that play a role in device operation and that may interface to one another via terminals
(i.e., POCTerminal class). Terminals may represent physical ports of various natures. Each sensor or
actuator embedded in the LoC possesses at least one terminal: the former displays a terminal through
which relevant sensing information is retrieved, whereas the latter exhibits a terminal through which
actuation can be commanded.
4.2. Hardware and Embedded Software Architecture
The performance requirements set by our elementary tasks led us to design an HWA powered
at 3.3 V, enabling the single-ended operation of its embedded analog and digital components.
It hosts a Bluetooth Low-Energy module (BLE112, Bluegiga Inc., Espoo, Finland) enabling wireless
communication with iOS. This module is configured as a master to a dual-core, C2000 Digital Signal
Controller (DSC-TMS320F28277D, Texas Instruments Inc., Dallas, TX, USA), so far interfaced via
a development breakout board [17] (Figure 6). Communication between the BLE112 module and the
DSC is assured using the standard Serial Peripheral Interface (SPI) protocol.
The dual-core architecture of the DSC is leveraged as follows: CPU1 is responsible for the
communication with the BLE112 module. As it receives encoded iOS instructions, it translates them into
settings for each ET. Upon loading of each ET setting, CPU1 triggers task initialization and execution on
CPU2. The DSC second core and its independent hardware accelerator are left responsible for voltage
generation functions and digital acquisitions by use of the DSC’s embedded 12-bit DACs or PWM
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modules, as well as its four embedded 12-bits ADCs in single-ended configuration. Parallelism allows
appropriate signal processing routines to be carried out on CPU1 and its own hardware accelerator,
while CPU2 keeps running its excitation/acquisition processes, for instance for continuous sensor
monitoring applications. Several DC voltages can be output in parallel. The signal processing routines
carried out by CPU1 allow digital filtering, decimation and current calibration of the sampled signals.
Their output triggers the upstream transmission of processed data to the BLE module that in turn
relays them to iOS.
Hardware redundancy, i.e., parallelism, another of Fricke’s design principles for changeability,
materializes as follows: twelve buffering operational amplifier stages are connected to the output of
both of the DSCs’ DACs and of ten of its PWM modules. These amplifiers were referenced at 1.8 V to
offer a theoretical AC output span of up to 1.5 V. Appropriate DAC or PWM waveform generation
routines and look-up tables are called depending on the LoC program mapping. Two potentiostatic
cells are implemented on the output of both DACs channels as described by others [50], using for
each two single-pole single-throw switches to select either a two- or three-electrode electrochemistry
configuration.
Figure 6. System hardware setup: The HWA materializes at this early development stage by
a development board hosting the HWA CPU (TI C2000 TMS320F28377D DSC) interfaced to a break-out
PCB embedding the analog signal conditioning circuitry and the BLE module. This PCB is here
interfaced to a single SPGE. iOS mobile application storyboard. (A–B) LoC configuration: define
the architecture and configuration of the LoC physically interfaced to the HWA; (C) low-level tasks’
definition: select and customize the low-level routines for acquisitions and/or actuation; (D) program
generation: select either low- or high-level tasks to define the sequence forming the LoC program;
(E) results: illustration of the cyclic-voltammetry acquisition data.
Twelve current Transimpedance Amplifiers (TIA) (AD8608, Analog Devices Inc., Norwood, MA,
USA) with each having four selectable gains (1× 104 h 3.6× 106 V·A−1) feed the multiplexed input of
the DSC’s ADCs, offering the opportunity to interface transducers presenting currents scaling over
several orders of magnitude.
Synchronous acquisitions can be defined so as to couple any of the excitation channels to any of
the acquisition channels. These twelve excitation channels and twelve acquisition channels constitute
the possible electrical interfaces for mapping current-acquisitions to LoC-embedded sensors.
4.3. Change-Absorbing Bluetooth Protocol
The two main interfaces of a smart device/HWA/LoC platform should be carefully designed as
change-absorbers. As such, the BLE communication protocol defining the interface between iOS and the
embedded firmware is one of the most sensitive throughout the platform. It must have vehicle-encoded
information of both LoC-program commands and retrieved data, virtually representing information
relevant to the function space, architectural space and mapping between the two.
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We designed our BLE protocol as a change absorber, with the objective to prevent the propagation
of anticipated changes in the functional or architectural space to other system modules or layers.
The encoding of any information from-to the mobile software layer must be carried onto
length-limited opcodes. iOS instructions to the HWA, for instance, are transmitted on the
AccessoryConfig20-byte attribute (Table 3).
Table 3. AccessoryConfig attribute value packet structure for synchronous acquisitions specifications.
Abbreviations: Channel (Ch.), Decimation factor (Decim.), Acquisition (acq.).
Byte 0 Byte 1 Byte 2 Byte 3–4 Byte 5–8
Sync.acq. Ch. ID Channel mode Paired exc.channel No. of acqs.periods Sampling freq.
Byte 9 (0:3) Byte 9 (4:7)–10 Byte 11 (0:3) Byte 11 (4:7) Byte 12 Byte 19
Sampl.order FPP Rf gain FIR sel. Decim. Ch.status
In order to absorb a potential expansion of the function or architectural space of the platform,
the fields carried by AccessoryConfig were represented with a provisional number of extra bits: the
Channel mode opcode byte, for instance, is designed to encode the operational mode of a target
excitation or acquisition channel in a single byte. Although currently only three modes have been
implemented, an entire byte encodes for the Channel mode attribute, making it possible for 255 modes
to be represented without having to modify the protocol. If Channel ID points to an acquisition
channel, then Channel mode will specify whether the targeted acquisition channel is synchronous
to one of the HWA excitation channels and what configuration options are implied. Similarly, the
Channel ID attribute is encoded over one byte, enabling the mapping of up to 255 acquisition channels
or 255 excitation channels should hardware redundancy be increased without affecting the iOS-DSC
firmware interface.
5. Operation and Experimental Measurements
We characterized the electrochemical capabilities of our system by interfacing one of its
electrochemical measurement channels to Screen-Printed Gold Electrodes (SPGE) (C223AT, DropSens).
The SPGEs were cleaned by sonication in ethanol for 10 min, then rinsed in distilled water before they
were allowed to dry at room temperature. We then proceeded to the electrochemical quantitation
of Dopamine (DA) solutions obtained from dopamine hydrochloride (Sigma-Aldrich, Saint-Louis,
MO, USA). A stock solution at 0.1 mol·L−1 and successive dilutions were prepared to obtain DA
concentrations down to 5.9× 10−9 mol·L−1. We used distilled water (Millipore Milli-Q, Bedford, MA,
USA) as a solvent. The dopamine solution was purged with nitrogen before the dilutions were realized.
Amperometry was carried out by setting the electrochemical cell at E = 0.6 V for 4 s and then
applying a potential E = −0.3 V for 20 s during which the current decay was measured at 100 samples
per second. Quantitation (HLT1 in Figure 2a) was obtained from the integration of the current signal
(i.e., charge) over the entire acquisition time. CV was performed using a scan rate of E = 100 mV·s−1 for
potentials ranging from E = −0.4 V to E = 0.4 V. HLT1 was designed to detect the reduction current
peak between −0.1 and 0.1 V. SWCV was configured with the same beginning and end potentials,
with increments of Eincr = 5 mV and pulse amplitudes of 80 mV at a frequency of E = 20 Hz. DPV
was similarly executed from E = 0.6 V to E = −0.2 V with a pulse duration of 0.04 s, an amplitude
of E = 50 mV and a potential step duration of 0.1 s. HLT1 for both SWCV and DPV implemented
a differential reduction peak current detection algorithm. The local maximum differential current
was probed for [−0.1–0.1] V for SWCV and [0–0.2] V for DPV. Current sensitivities (i.e., reciprocal
of the current amplifier gain) were specified programmatically so as to maximize the signal-to-noise
ratio for a given DA dilution. Each calibration point was obtained by averaging results from three
measurements.
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Once the calibration methods were available, we carried out the fully-automated quantitation
of two DA solutions with nominal concentrations of 4× 10−3 mol·L−1 and 40× 10−6 mol·L−1,
respectively. Measurements were performed five times for each solution. Gain/sensitivity was
initially set to its maximum value (Gain = 3.6× 106 V·A−1). HLT2 replaced HLT1 for this automated
quantitation. HLT2 was implemented with a current-saturation detection algorithm in order to
determine whether the acquisition should be repeated with a lower input current-gain. Current
saturation was probed for within the specified potential range for which we searched for the local
maxima/minima. Should saturation be detected, then the LLT was repeated at the directly inferior
gain. This scheme was repeated iteratively until no saturation occurred or once the lowest sensitivity
was reached (1× 10−4 A·V−1).
An illustration of the acquisition data retrieved at the mobile software layer for each method
is given in Figure 7. For each acquisition, a calibration point was retrieved from either identifying
a local current maxima/minima (i.e., for CV, SWCV and DPV) or by integrating current over the entire
acquisition sequence (i.e., for amperometry). From these points, we could derive the calibration curves
presented in Figure 7e–h. Regression results are given in Table 4. The calibration curve for amperometry
(Figure 7h) was obtained by using a segmented log-log regression, each segment corresponding to the
input current sensitivity used for the acquisition. This method allowed us to correct for the total error
accumulated from the integration of the current gain and offset errors summed over the acquisition
time. For all electrochemical methods, our calibration curves span over several orders of magnitude
of DA concentrations with regression coefficients up to 0.996, benefiting from the scalability of the
selectable current amplifiers sensitivities.
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Figure 7. Mobile phone acquisition data. (a) Cyclic voltammograms: the calibration point is obtained
from retrieving local maxima around E = 0 V; (b) SWCV acquisitions: the calibration point is obtained
from retrieving local maxima around E = 0 V; (c) DPV acquisitions: the calibration point is obtained
from retrieving local maxima for 0 < E < 0.2 V; (d) amperometry: the calibration point is obtained
by integrating the current value for the entire duration of the acquisition. Saturated acquisitions are
only discarded when saturation occurs within the potential range of interest. In the specific case of
amperometry, acquisitions are discarded if the current is saturated at t = 0 (e.g., acquisition at 25 mol·L−1
in quadrant d was discarded and repeated with a lower input current sensitivity). (e–h) Calibration
curves for electrochemical scheme respectively illustrated in (a–d).
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Table 4. Calibration of the various electroanalytical schemes for dopamine detection. Abbreviations:
Single regression (Sing. regr.), Segmented regression (Seg. regr.).
Calibration Solution
Concentration Range R2
LOD
(×10−6 mol·L−1) Accuracy (%)
min ×10−6mol·L−1 max ×10−6mol·L−1 @ 4× 10
−3 mol·L−1 @ 40× 10−6 mol·L−1
Sing.regr. Segm.regr. Sing. regr. Segm. regr.
CV 97.6 50 × 103 0.982 0.213 86.8 89.3 58.3 78.2
SWCV 48.5 12.5 × 103 0.996 0.611 90 91.8 82.5 87.5
DPV 12.2 50 × 103 0.988 0.324 70 82.7 77.6 86
Amperometry @ 1× 10
5 V·A−1 12.2 0.1953 × 103 0.921 0.347 — — — 46.7
@ 1× 104 V·A−1 0.1953 50 × 103 0.977 — — 86.9 — —
Finally, the fully-automated quantitation of DA was achieved with accuracies reaching up to 91.8%.
By applying a segmented regression (i.e., one for each current sensitivity) also for CV, SWCV and
DPV, accuracies could be improved by up to 12.7% for DA at 4× 10−3 mol·L−1 and up to 19.9% for
DA at 40× 10−6 mol·L−1. Although the achieved LODs do not reach levels documented on other
sensing systems (e.g., [52–54]), they were obtained from generic commercial electrochemical sensors.
This suggests potential for performance optimization, which is out of the scope of this research work.
6. Discussion
The framework we propose in this paper aims at promoting system evolvability in smart
devices/LoC systems mainly through the implementation of design principles for changeability
at the HWA and software level. It thus supplements conventional PBD methodologies for CPS.
Assuming the universality of these design principles, we must yet still discuss the implications of
their implementation: The non-hierarchical integration of the platform functionality at the mobile
software layer provides significant freedom of action as to how to post-process the LoC acquisition
data in higher level abstraction layers: in mobile software or potentially in the cloud. This property
is valuable in a context where -omics sequencing technologies are increasingly coupled to cloud
supercomputing analytics and AI [55,56]. Furthermore, we must not forget that PoC IVMD systems
are user-centric systems. The smart device is pivotal in handling user interaction and in articulating
the information from chip to cloud. Similarly, the composition of LoC programs intertwining modular
low- and high-level tasks offers significant LoC programmability advantages: high-level tasks
return values that can be used to modify ensuing LoC program instructions at run time. LoC
program conditional branching could thus rely on the evaluation of user-queried or cloud-computing
return properties.
This non-hierarchical design yet puts a certain number of constraints on the system requirements,
notably on the mobile software/embedded firmware wireless interface. As we mentioned earlier, we
strove to design the iOS/embedded firmware protocol as a change absorber to the expansion of the
software functional space or to the expansion of the HWA or LoC architectural or functional space.
That interface itself must be robust enough to maintain LoC operation even when the smart device
(and often its user) is remotely located from the LoC. This, in turn, may imply the wireless transmission
of mobile software commands to the HWA via wireless networks and reciprocally the transmission of
acquisition data from the HWA to the mobile software layer over these networks. This scenario entails
security and privacy concerns, as well as response time considerations should any of the LoC processes
be time-critical. We deliberately set these issues aside during our investigation, but we acknowledge
that they are of paramount importance.
Our search for modularity enabled us to implement electrochemical capabilities for our platform
by the sole functional composition of existing ETs at the mobile software layer and did not require
change to any other system components. The composability of ETs is essential for enabling the
incorporation of new physical functionality on the platform. It is yet not easily implemented.
Redundancy is probably the most obvious of the design principles favoring evolvability.
Although our current platform allows the interfacing of up to 12 current readout channels, many more
could have been included with a hardware design inspired from Micro Electrode Array (MEA) systems.
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One of the arguments against a high level of redundancy/parallelism is the obvious costs of duplicating
hardware structures and design controllers capable of running in parallel or in a fast multiplexed
manner. In our specific case, duplicating the analog front end current amplifiers alone would at a
certain point have required shifting from off-the-shelf components to technologies offering higher
levels of integration, such as Application-Specific Integrated Circuits (ASIC), a much costlier design
choice. This introduces an important notion in design for evolvability: decisions supporting system
evolvability in design must be accompanied both by uncertainty assessment and valuation techniques
in order to determine the cost of embedding evolvability at the initial design time, compared to the
projected costs associated with the anticipated needed change [57]. Our research work did not address
these considerations, rather focusing on where and how could system evolvability be promoted in the
initial architecture of smart device/LoC platforms.
The framework we propose in this paper is to our knowledge the first to formally focus on system
evolvability as a solution to the socio-technical roadblocks that today still prevent the generalization
of LoC technologies in the consumer market. Although we argue this framework can favor the
development, adoption and lasting success of next-generation direct-to-consumer PoC systems, we
acknowledge that it only partially answers current challenges in IVMD. In particular, it does not
substitute the need for cutting edge biosensors and detection methods allowing the recovery of minute
quantities of molecules of importance. It also does not account for the integration challenges of these
sensing and actuation technologies into small, mass-producible, low-cost LoCs. On that account, our
framework can merely inspire LoC designers to work in closer collaboration with instrumentation
teams to ensure the overall evolvability both of the platform initially conceptualized and that of
the LoC modules themselves. We anticipate that the availability of evolvable PoC instrumentation
platforms can encourage the development of new biodetection technologies specifically designed to be
compatible with these platforms, thus streamlining IVMD tests development and commercialization.
7. Conclusions
We presented in this work a PBD methodology aiming at embedding evolvability in LoC/smart
device PoC systems. Our findings should help reinforce the interest for and viability of the PoC
IVMD direct-to-consumer business model. We proposed a design methodology for incorporating
change-enablers and change-absorbers in smart device/LoC systems hardware and software in
search of promoting system evolvability. We demonstrated the applicability of our methodology by
implementing a prototype allowing, at this stage, the interfacing of modular, passive LoCs embedding
current- or impedance-based biosensors. We finally demonstrated the operation of our platform by
carrying out the electrochemical detection of dopamine using various analytical schemes.
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BLE Bluetooth Low Energy
CPS Cyber-Physical Systems
CV Cyclic Voltammetry
DA Dopamine
DAC Digital to Analog Converter
DPV Differential Pulse Voltammetry
DSC Digital Signal Controller
ETs Elementary Tasks
HLTs High-Level Tasks
HWA Hardware Accessory
IVMD In Vitro Medical Diagnostics
LLTs Low-Level Tasks
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PoC Point-of-Care
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SWCV Square Wave Cyclic Voltammetry
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